131 related articles for article (PubMed ID: 33636536)
1. Synthesis of artemisinin-piperazine-furan ether hybrids and evaluation of in vitro cytotoxic activity.
Wei MX; Yu JY; Liu XX; Li XQ; Zhang MW; Yang PW; Yang JH
Eur J Med Chem; 2021 Apr; 215():113295. PubMed ID: 33636536
[TBL] [Abstract][Full Text] [Related]
2. [Synthesis and bioactivities of novel dihydroartemisinin-piperazine derivatives containing sulfonamide].
Ma C; Li XQ; Xu J; Chen CX
Yao Xue Xue Bao; 2013 Sep; 48(9):1430-5. PubMed ID: 24358777
[TBL] [Abstract][Full Text] [Related]
3. Design, Synthesis, and Biological Evaluation of Artemisinin-Piperazine-Phosphoramide Mustard Hybrids as Potential Anticancer Agents.
Wei MX; Zhang SS; Sun X; Ji Y; Yang PW; Li XQ
ChemMedChem; 2022 Sep; 17(17):e202200239. PubMed ID: 35771689
[TBL] [Abstract][Full Text] [Related]
4. Synthesis of Tamoxifen-Artemisinin and Estrogen-Artemisinin Hybrids Highly Potent Against Breast and Prostate Cancer.
Fröhlich T; Mai C; Bogautdinov RP; Morozkina SN; Shavva AG; Friedrich O; Gilbert DF; Tsogoeva SB
ChemMedChem; 2020 Aug; 15(15):1473-1479. PubMed ID: 32374071
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and biological activities of artemisinin-piperazine-dithiocarbamate derivatives.
Yu JY; Li XQ; Wei MX
Eur J Med Chem; 2019 May; 169():21-28. PubMed ID: 30852384
[TBL] [Abstract][Full Text] [Related]
6. Design, synthesis, molecular docking and cytotoxic evaluation of novel 2-furybenzimidazoles as VEGFR-2 inhibitors.
Abdullaziz MA; Abdel-Mohsen HT; El Kerdawy AM; Ragab FAF; Ali MM; Abu-Bakr SM; Girgis AS; El Diwani HI
Eur J Med Chem; 2017 Aug; 136():315-329. PubMed ID: 28505536
[TBL] [Abstract][Full Text] [Related]
7. Artemisinin-indole and artemisinin-imidazole hybrids: Synthesis, cytotoxic evaluation and reversal effects on multidrug resistance in MCF-7/ADR cells.
Hu Y; Li N; Zhang J; Wang Y; Chen L; Sun J
Bioorg Med Chem Lett; 2019 May; 29(9):1138-1142. PubMed ID: 30837097
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and biological evaluation of novel artemisone-piperazine-tetronamide hybrids.
Wei MX; Yu JY; Liu XX; Li XQ; Yang JH; Zhang MW; Yang PW; Zhang SS; He Y
RSC Adv; 2021 May; 11(30):18333-18341. PubMed ID: 35480921
[TBL] [Abstract][Full Text] [Related]
9. Design, synthesis and biological evaluation of artemisinin derivatives containing fluorine atoms as anticancer agents.
Li S; Li G; Yang X; Meng Q; Yuan S; He Y; Sun D
Bioorg Med Chem Lett; 2018 Jul; 28(13):2275-2278. PubMed ID: 29789258
[TBL] [Abstract][Full Text] [Related]
10. Synthesis of a novel series of artemisinin dimers with potent anticancer activity involving Sonogashira cross-coupling reaction.
Buragohain P; Saikia B; Surineni N; Barua NC; Saxena AK; Suri N
Bioorg Med Chem Lett; 2014 Jan; 24(1):237-9. PubMed ID: 24332623
[TBL] [Abstract][Full Text] [Related]
11. Artemisinin-isatin hybrids tethered via ethylene linker and their anti-lung cancer activity.
Wang R; Zhang Q; Chen M
Arch Pharm (Weinheim); 2023 Apr; 356(4):e2200563. PubMed ID: 36572639
[TBL] [Abstract][Full Text] [Related]
12. Novel dibenzo[b,d]furan-1H-1,2,4-triazole derivatives: Synthesis and antitumor activity.
Chen X; Shi YM; Huang C; Xia S; Yang LJ; Yang XD
Anticancer Agents Med Chem; 2016; 16(3):377-86. PubMed ID: 26278547
[TBL] [Abstract][Full Text] [Related]
13. Design, synthesis, and biological evaluation of artemisinin-indoloquinoline hybrids as potent antiproliferative agents.
Wang L; Świtalska M; Wang N; Du ZJ; Fukumoto Y; Diep NK; Kiguchi R; Nokami J; Wietrzyk J; Inokuchi T
Molecules; 2014 Nov; 19(11):19021-35. PubMed ID: 25412047
[TBL] [Abstract][Full Text] [Related]
14. Design, Synthesis, and Biological Evaluation of Novel Amyl Ester Tethered Dihydroartemisinin-Isatin Hybrids as Potent Anti-Breast Cancer Agents.
Xu Z; Zhang X; Liu J; Zhao S; Liu J; Zhou W
Chem Biodivers; 2023 Mar; 20(3):e202201257. PubMed ID: 36808231
[TBL] [Abstract][Full Text] [Related]
15. Identification of Novel Artemisinin Hybrids Induce Apoptosis and Ferroptosis in MCF-7 Cells.
Zhong Y; Li ZN; Jiang XY; Tian X; Deng MH; Cheng MS; Yang HL; Liu Y
Int J Mol Sci; 2022 Dec; 23(24):. PubMed ID: 36555409
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and anticancer activity of novel deoxoartemisinin-glycolipid hybrids.
Min D; Kim M; Ricci J; Jung S; Kim K; Chung WY; Park KK; Jung M
Chem Pharm Bull (Tokyo); 2014; 62(5):446-53. PubMed ID: 24614158
[TBL] [Abstract][Full Text] [Related]
17. [Design, synthesis and antiproliferative activities of artemisinin derivatives substituted by N-heterocycles].
Zuo ZZ; Zhong H; Cai T; Bao Y; Liu ZQ; Liu D; Zhao LX
Yao Xue Xue Bao; 2015 Jul; 50(7):868-74. PubMed ID: 26552149
[TBL] [Abstract][Full Text] [Related]
18. Design, synthesis, and in vitro cytotoxicity evaluation of novel dihydroartemisinin-isatin hybrids tethered via different length of esters as potential anti-breast cancer agents.
Xu Z; Pan B; Chen L; Xu D
Fitoterapia; 2023 Apr; 166():105436. PubMed ID: 36693438
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and cytotoxic activity of new artemisinin hybrid molecules against human leukemia cells.
Letis AS; Seo EJ; Nikolaropoulos SS; Efferth T; Giannis A; Fousteris MA
Bioorg Med Chem; 2017 Jul; 25(13):3357-3367. PubMed ID: 28456567
[TBL] [Abstract][Full Text] [Related]
20. Synthesis of a series of novel dihydroartemisinin monomers and dimers containing chalcone as a linker and their anticancer activity.
Gaur R; Pathania AS; Malik FA; Bhakuni RS; Verma RK
Eur J Med Chem; 2016 Oct; 122():232-246. PubMed ID: 27371926
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
